Kozak MJ - Search Results

1

Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder.

Kozak MJ, Foa EB. Kozak MJ, et al. Behav Res Ther. 1994 Mar;32(3):343-53. doi: 10.1016/0005-7967(94)90132-5. Behav Res Ther. 1994. PMID: 8192634 Review.

2

Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.

Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X. Foa EB, et al. Among authors: kozak mj. Am J Psychiatry. 2005 Jan;162(1):151-61. doi: 10.1176/appi.ajp.162.1.151. Am J Psychiatry. 2005. PMID: 15625214 Clinical Trial.

3

Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.

Hembree EA, Riggs DS, Kozak MJ, Franklin ME, Foa EB. Hembree EA, et al. Among authors: kozak mj. CNS Spectr. 2003 May;8(5):363-71, 381. doi: 10.1017/s1092852900018629. CNS Spectr. 2003. PMID: 12766692 Clinical Trial.

4

Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder.

Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, Petkova E, Kjernisted K, Huppert JD, Franklin ME, Davies SO, Campeas R. Simpson HB, et al. Among authors: kozak mj. Depress Anxiety. 2004;19(4):225-33. doi: 10.1002/da.20003. Depress Anxiety. 2004. PMID: 15274171 Clinical Trial.

5

Effects of imipramine on depression and obsessive-compulsive symptoms.

Foa EB, Steketee G, Kozak MJ, Dugger D. Foa EB, et al. Among authors: kozak mj. Psychiatry Res. 1987 Jun;21(2):123-36. doi: 10.1016/0165-1781(87)90070-9. Psychiatry Res. 1987. PMID: 3615688 Clinical Trial.

6

Implicit and explicit memory in obsessive-compulsive disorder.

Foa EB, Amir N, Gershuny B, Molnar C, Kozak MJ. Foa EB, et al. Among authors: kozak mj. J Anxiety Disord. 1997 Mar-Apr;11(2):119-29. doi: 10.1016/s0887-6185(97)00001-7. J Anxiety Disord. 1997. PMID: 9168337

7

Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.

Goodman WK, Kozak MJ, Liebowitz M, White KL. Goodman WK, et al. Among authors: kozak mj. Int Clin Psychopharmacol. 1996 Mar;11(1):21-9. Int Clin Psychopharmacol. 1996. PMID: 8732310 Clinical Trial.

8

Relapse prevention program for treatment of obsessive-compulsive disorder.

Hiss H, Foa EB, Kozak MJ. Hiss H, et al. Among authors: kozak mj. J Consult Clin Psychol. 1994 Aug;62(4):801-8. doi: 10.1037//0022-006x.62.4.801. J Consult Clin Psychol. 1994. PMID: 7962884 Clinical Trial.

9

DSM-IV field trial: obsessive-compulsive disorder.

Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. Foa EB, et al. Among authors: kozak mj. Am J Psychiatry. 1995 Jan;152(1):90-6. doi: 10.1176/ajp.152.1.90. Am J Psychiatry. 1995. PMID: 7802127 Clinical Trial.

10

Effects of imipramine on the autonomic responses of obsessive-compulsives to auditory tones.

Kozak MJ, Rossi M, McCarthy PR, Foa EB. Kozak MJ, et al. Biol Psychiatry. 1989 Nov;26(7):707-16. doi: 10.1016/0006-3223(89)90105-4. Biol Psychiatry. 1989. PMID: 2804191 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results